These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses? Hon KL; Leung TF; Leung AK Drug Des Devel Ther; 2014; 8():839-50. PubMed ID: 25061277 [TBL] [Abstract][Full Text] [Related]
23. Safety of using montelukast during pregnancy. Koren G; Sarkar M; Einarson A Can Fam Physician; 2010 Sep; 56(9):881-2. PubMed ID: 20841587 [TBL] [Abstract][Full Text] [Related]
24. A review of montelukast in the treatment of asthma and allergic rhinitis. Nayak A Expert Opin Pharmacother; 2004 Mar; 5(3):679-86. PubMed ID: 15013935 [TBL] [Abstract][Full Text] [Related]
26. Leukotriene modifiers in pediatric asthma management. Bisgaard H Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473 [TBL] [Abstract][Full Text] [Related]
27. Montelukast. No current use for asthma. Can Fam Physician; 2000 Jan; 46():86-99. PubMed ID: 10660791 [TBL] [Abstract][Full Text] [Related]
28. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients. Virchow JC; Mehta A; Ljungblad L; Mitfessel H J Asthma; 2010 Nov; 47(9):986-93. PubMed ID: 20858152 [TBL] [Abstract][Full Text] [Related]
29. Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis. Zhang HP; Jia CE; Lv Y; Gibson PG; Wang G Allergy Asthma Proc; 2014; 35(4):278-87. PubMed ID: 24992547 [TBL] [Abstract][Full Text] [Related]
30. [Churg-Strauss syndrome after treatment with Singulair (montelukast)]. Hammer HB; Aukrust P; Frøland SS Tidsskr Nor Laegeforen; 2002 Feb; 122(5):484-6. PubMed ID: 11961976 [TBL] [Abstract][Full Text] [Related]
31. Montelukast in childhood asthma. Mehta PN Indian Pediatr; 2000 Nov; 37(11):1201-9. PubMed ID: 11086302 [No Abstract] [Full Text] [Related]
33. Leukotriene modifiers: new drugs, old and new reactions. Rosenwasser LJ J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):374-5. PubMed ID: 10069868 [No Abstract] [Full Text] [Related]
34. Recent advances in the management of asthma using leukotriene modifiers. Kemp JP Am J Respir Med; 2003; 2(2):139-56. PubMed ID: 14720013 [TBL] [Abstract][Full Text] [Related]
35. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Robinson DS; Campbell D; Barnes PJ Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132 [TBL] [Abstract][Full Text] [Related]
36. Montelukast for the treatment of asthma in the adult population. Amlani S; Nadarajah T; McIvor RA Expert Opin Pharmacother; 2011 Sep; 12(13):2119-28. PubMed ID: 21777174 [TBL] [Abstract][Full Text] [Related]
37. [What is the role of montelukast in asthma treatment?]. Aksu K; Aksu F Tuberk Toraks; 2020 Sep; 68(3):328-330. PubMed ID: 33295731 [TBL] [Abstract][Full Text] [Related]
38. Montelukast-associated Churg-Strauss vasculitis: another associated report. Black JG; Bonner JR; Boulware D; Andea AA Ann Allergy Asthma Immunol; 2009 Apr; 102(4):351-2. PubMed ID: 19441609 [No Abstract] [Full Text] [Related]
39. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189 [TBL] [Abstract][Full Text] [Related]
40. Montelukast-induced adverse drug reactions: a review of case reports in the literature. Calapai G; Casciaro M; Miroddi M; Calapai F; Navarra M; Gangemi S Pharmacology; 2014; 94(1-2):60-70. PubMed ID: 25196099 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]